{
    "eid": "2-s2.0-85074844457",
    "title": "Compound Heterozygous PGM3 Mutations in a Thai Patient with a Specific Antibody Deficiency Requiring Monthly IVIG Infusions",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [],
    "authors": [
        "Chupong Ittiwut",
        "Wiparat Manuyakorn",
        "Siraprapa Tongkobpetch",
        "Suwat Benjaponpitak",
        "Megan R. Fisher",
        "Joshua D. Milner",
        "Jonathan J. Lyons",
        "Kanya Suphapeetiporn",
        "Vorasuk Shotelersuk"
    ],
    "citedby-count": 3,
    "ref-count": 12,
    "ref-list": [
        "Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels",
        "Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment",
        "Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene",
        "PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia",
        "Neonatal-onset T(-)B(-)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3",
        "A novel PGM3 mutation is associated with a severe phenotype of bone marrow failure, severe combined immunodeficiency, skeletal dysplasia, and congenital malformations",
        "A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients",
        "Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report",
        "M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity",
        "Detection of phosphoglucomutase-3 deficiency by lectin-based flow cytometry",
        "Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients",
        "Resolution of disease phenotypes resulting from multilocus genomic variation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bethesda",
            "@id": "60017336",
            "affilname": "National Institute of Allergy and Infectious Diseases (NIAID)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017336",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn Academic Advancement",
        "US Government",
        "NIH",
        "National Institute of Allergy and Infectious Diseases",
        "Thailand Research Fund"
    ]
}